Cogent Biosciences Stock Market Value
| COGT Stock | USD 9.62 0.32 3.44% |
| Symbol | Cogent |
Cogent Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cogent Biosciences. If investors know Cogent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cogent Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cogent Biosciences is measured differently than its book value, which is the value of Cogent that is recorded on the company's balance sheet. Investors also form their own opinion of Cogent Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cogent Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cogent Biosciences' market value can be influenced by many factors that don't directly affect Cogent Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cogent Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cogent Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cogent Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cogent Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cogent Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cogent Biosciences.
| 01/01/2025 |
| 01/31/2025 |
If you would invest 0.00 in Cogent Biosciences on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Cogent Biosciences or generate 0.0% return on investment in Cogent Biosciences over 30 days. Cogent Biosciences is related to or competes with Larimar Therapeutics, Kura Oncology, Kiniksa Pharmaceuticals, Ideaya Biosciences, AnaptysBio, MeiraGTx Holdings, and Keros Therapeutics. Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined dis... More
Cogent Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cogent Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cogent Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 18.81 | |||
| Value At Risk | (7.21) | |||
| Potential Upside | 5.43 |
Cogent Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cogent Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cogent Biosciences' standard deviation. In reality, there are many statistical measures that can use Cogent Biosciences historical prices to predict the future Cogent Biosciences' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | 0.6063 |
Cogent Biosciences Backtested Returns
Cogent Biosciences secures Sharpe Ratio (or Efficiency) of -0.0634, which signifies that the company had a -0.0634 % return per unit of risk over the last 3 months. Cogent Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cogent Biosciences' Mean Deviation of 2.66, standard deviation of 4.02, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.44, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cogent Biosciences are expected to decrease at a much lower rate. During the bear market, Cogent Biosciences is likely to outperform the market. At this point, Cogent Biosciences has a negative expected return of -0.27%. Please make sure to confirm Cogent Biosciences' total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if Cogent Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.14 |
Insignificant predictability
Cogent Biosciences has insignificant predictability. Overlapping area represents the amount of predictability between Cogent Biosciences time series from 1st of January 2025 to 16th of January 2025 and 16th of January 2025 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cogent Biosciences price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Cogent Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.27 |
Cogent Biosciences lagged returns against current returns
Autocorrelation, which is Cogent Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cogent Biosciences' stock expected returns. We can calculate the autocorrelation of Cogent Biosciences returns to help us make a trade decision. For example, suppose you find that Cogent Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cogent Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cogent Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cogent Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cogent Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Cogent Biosciences Lagged Returns
When evaluating Cogent Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cogent Biosciences stock have on its future price. Cogent Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cogent Biosciences autocorrelation shows the relationship between Cogent Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Cogent Biosciences.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.